{"id":14732,"date":"2025-03-02T10:37:31","date_gmt":"2025-03-02T15:37:31","guid":{"rendered":"https:\/\/whizkid.com\/a4pc\/?p=14732"},"modified":"2025-03-03T10:38:48","modified_gmt":"2025-03-03T15:38:48","slug":"usa-todays-balanced-article-on-the-future-of-glp-1s","status":"publish","type":"post","link":"https:\/\/whizkid.com\/a4pc\/2025-03\/usa-todays-balanced-article-on-the-future-of-glp-1s\/","title":{"rendered":"USA Today\u2019s balanced article on the future of GLP-1s"},"content":{"rendered":"<p>One of the better articles we&#8217;ve seen lately comes from USA Today, explaining what is likely to happen to patients taking GLP-1 drugs since the FDA declared the semaglutide shortage over. (Of course it quoted APC \u2014 both CEO Scott Brunner and Pharmacy Compounding Foundation Chair Jenn Burch.)\u00a0<\/p>\n<p>&#8220;<a href=\"https:\/\/www.usatoday.com\/story\/money\/2025\/03\/02\/deadline-discounted-weight-loss-drugs-what-to-know\/80268480007\/\" rel=\"noopener\">These discounted versions of popular weight-loss drugs are going away: What to know<\/a>&#8221; focuses on the transition from compounded drugs to their brand-name counterparts without editorializing about how the FDA (may have) acted too soon in its shortage-ending declaration. &#8216;How will patients afford it?&#8217; is the overarching question \u2014 and that&#8217;s one of ours, too.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>USA Today turns to APC to answer the question &#8216;What are patients going to do now?&#8217;<br \/><span class=\"read-more\"><a target=\"_blank\" href=\"https:\/\/whizkid.com\/a4pc\/2025-03\/usa-todays-balanced-article-on-the-future-of-glp-1s\/\"><\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":14715,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[114],"tags":[],"class_list":["post-14732","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-inthenews"],"_links":{"self":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/posts\/14732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/comments?post=14732"}],"version-history":[{"count":1,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/posts\/14732\/revisions"}],"predecessor-version":[{"id":14733,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/posts\/14732\/revisions\/14733"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/media\/14715"}],"wp:attachment":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/media?parent=14732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/categories?post=14732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/tags?post=14732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}